Jump to content

Benign melanocytic nevus

From Wikipedia, the free encyclopedia
(Redirected from Nevocytic nevus)
Benign melanocytic nevus
Other namesBanal nevus, Common acquired melanocytic nevus, Mole, Nevocellular nevus, and Nevocytic nevus.
Seen is a normal mole, with no difference in shades of brown, black, or tan. Part of the ABCDs for detection of melanoma.
SpecialtyDermatology
TypesJunctional, intradermal, and compound.

A benign melanocytic nevus is a cutaneous condition characterised by well-circumscribed, pigmented, round or ovoid lesions, generally measuring from 2 to 6 mm in diameter.[1] A benign melanocytic nevus may feature hair or pigmentation as well.

Types

[edit]

The three most common categories of benign melanocytic nevi are those located at the border between the epidermis and dermis (junctional nevi), intradermal nevi in the dermis only, and those found in both the dermis and epidermis (compound nevi).[2][3]

Types of benign melanocytic nevi
Height Color
Junctional Flat Brown-black
Intradermal Slightly elevated Light brown-brown
Compound Dome-shaped Flesh-colored or brown

Epidemiology

[edit]

This skin lesion is quite common in the population, and it can present at birth, known as a congenital meloncytic nevus, or later in life as an acquired nevus. Should the nevi appear in toddler- or school-aged children, they are more likely to remain present throughout the rest of that person's life.[4] If they arise in adolescence and adulthood, the nevi most likely occur due to sun damage. With appropriate coverage from the sun, these lesions may go away over time. Also, lighter-skinned people tend to have nevi more frequently than dark-skinned people.

[edit]

There is a distinction between a benign melanocytic nevus and melanoma, a type of skin cancer. Both of these conditions originate from the same type of cell: the melanocyte. However, a melanocytic nevus is benign, and melanoma is malignant. Most melanocytic nevi never evolve into a cancer, with the lifetime risk for an individual nevus being 1 in 3000 for men and 1 in 11 000 for women.[5] Moreover, dermatologists have a standardized system for determining whether a skin lesion is suspicious for malignant melanoma. It is as follows:

Differentiating mole from melanoma (ABCDE)
A Asymmetry

One half of the lesion does not look like the other

B Borders

The edges of the lesion are jagged or blurred

C Color (variegation)

The color of the lesion is not uniform; instead, it feature multiple colors

D Diameter

The lesion is greater than 1/4 inch or 6 mm from one side to the other

E Evolution

The lesion changes in appearance over time, such as in size or color

The above table features each warning sign for suspected melanoma. If a person notes that they have a skin lesion with some of these characteristics, a dermatologist would be able to help them with further evaluation. If melanoma is detected and treated early before it spreads in a process called metastasis, it carries a good prognosis.

See also

[edit]

References

[edit]
  1. ^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 978-1-4160-2999-1.
  2. ^ "Benign Melanocytic Nevus - an overview | ScienceDirect Topics". www.sciencedirect.com. Retrieved 2020-11-07.
  3. ^ "Nevus - Dermatology - Medbullets Step 1". step1.medbullets.com. Retrieved 2020-11-07.
  4. ^ "Melanocytic naevus | DermNet NZ". dermnetnz.org. Retrieved 2020-11-07.
  5. ^ Damsky, WE; Bosenberg, M (2017-10-19). "Melanocytic nevi and melanoma: unraveling a complex relationship". Oncogene. 36 (42): 5771–5792. doi:10.1038/onc.2017.189. ISSN 0950-9232. PMC 5930388. PMID 28604751.